Grant RadarWorldwide funding
Log inGet started
Back to Grants
Health Open for ApplicationsRFA-HL-26-017

Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trial

National Institutes of Health opportunity RFA-HL-26-017

Eligible Applicants
Organization Types
UniversitiesNGOsSMEsGovernment Agencies
Eligible Countries / Regions
United States
Keywords
National Institutes of HealthRFA-HL-26-017Grants.gov
Related Grants
HealthUpcoming
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
Varies
Health● Open
Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed)
Varies
07 May 2027(217d)
HealthUpcoming
FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)
Varies
HealthUpcoming
FDA OMHHE Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed
Varies
Funding Amount
Varies
USD
Application Deadline
23 December 2027
447 days remaining
Opens: 22 Nov 2024
Apply Now
Programme Details
Programme Code
RFA-HL-26-017